BMRN - BioMarin could be very 'digestible' to larger cap peers in US/Europe - analyst
2023-11-07 14:50:25 ET
More on BioMarin Pharmaceutical
- BioMarin: Keeping Bullish View After Q3 Earnings
- BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation
- Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript
- Elliott could push for sale, cost cutting at BioMarin - analyst
- Biggest stock movers today: BioMarin, Alteryx, Tripadvisor and more
For further details see:
BioMarin could be very 'digestible' to larger cap peers in US/Europe - analyst